Receptor for advanced glycation end products (RAGE) in a dash to the rescue: Inflammatory signals gone awry in the primal response to stress

Journal of Leukocyte Biology

Volumn 82, Issue 2, 2007, Pages 204-212

  Herold, Kevan ^a   Moser, Bernhard ^b   Chen, Yali ^b   Zeng, Shan ^b   Shi, Fang Yan ^b   Ramasamy, Ravichandran ^b   Emond, Jean ^b   Clynes, Raphael ^b   Schmidt, Ann Marie ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Immunity; Inflammation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMYLOID BETA PROTEIN[25-35]; CALGRANULIN; CD11B ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; PROTEIN S 100;

ADAPTIVE IMMUNITY; BETA SHEET; CD4+ T LYMPHOCYTE; CHRONIC DISEASE; IMMUNE RESPONSE; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS; T LYMPHOCYTE; TISSUE INJURY; UPREGULATION;

ANIMALS; HUMANS; INFLAMMATION; MODELS, IMMUNOLOGICAL; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; STRESS;

EID: 34547728254     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1206751     Document Type: Review

References (59)

1. Beisswenger, P. J., Howell, S. K., Nelson, R. G., Mauer, M., Szwergold, B. S. (2003) α-Oxoaldehyde metabolism and diabetic complications. Biochem. Soc. Trans. 31, 1358-1363.
2. Brownlee, M. (1996) Advanced glycation endproducts in diabetic complications. Curr. Opin. Endocrinol. Diabetes 3, 291-297.
3. Girones, X., Guuimera, A., Cruz-Sanchez, C. Z., Ortega, A., Sasaki, N., Makita, Z., Lafuente, J. V., Kalaria, R., Cruz-Sanchez, F. F. (2004) Nε carboxymethyllysine in brain aging, diabetes mellitus and Alzheimer's disease. Free Radic. Biol. Med. 36, 1241-1247.
4. Ikeda, K., Higashi, T., Sano, H., Jinnouchi, Y., Yoshida, M., Araki, T., Ueda, S., Horiuchi, S. (1996) Carboxymethyllysine protein adduct is a major immunological epitope in proteins modified with AGEs of the Maillard reaction. Biochemistry 35, 8075-8083.
5. Brown, B. E., Dean, R. T., Davies, M. J. (2005) Glycation of low density lipoproteins by methylglyoxal and glycoaldehyde gives rise to the in vitro formation of lipid-laden cells. Diabetologia 48, 361-369.
6. Wautier, M. P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., Wautier, J. L. (2001) Activation of NADPH oxidase by advanced glycation endproducts (AGEs) links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab. 280, E685-E694.
7. Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., Stern, D. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation endproducts with their receptors/binding proteins. J. Biol. Chem. 269, 9889-9897.
8. Basta, G., Lazzerini, G., Del Turco, S., Ratto, G. M., Schmidt, A. M., De Caterina, R. (2005) At least two distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler. Thromb. Vasc. Biol. 25, 1401-1407.
9. Anderson, M. M., Requena, J. R., Crowley, J. R., Thorpe, S. R., Heinecke, J. W. (1999) The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J. Clin. Invest. 104, 103-113.
10. Anderson, M. M., Heinecke, J. W. (2003) Production of N(ε)-(carboxymethyl) lysine is impaired in mice deficient in NADPH oxidase: a role for phagocyte-derived oxidants in the formation of advanced glycation endproducts during inflammation. Diabetes 52, 2137-2143.
11. Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Yan, S. D., Hofmann, M., Yan, S. F., Pischetsrider, M., Stern, D., Schmidt, A. M. (1999) Ne (carboxymethyl)lysine modifications of proteins are ligands for RAGE that activate cell signaling pathways and modulate gene expression. J. Biol. Chem. 274, 31740-31749.
12. Oudes, A. J., Herr, C. M., Olsen, Y., Fleming, J. E. (1998) Age-dependent accumulation of advanced glycation end-products in adult Drosophila melanogaster. Mech. Ageing Dev. 100, 221-229.
13. Mironova, R., Niwa, T., Handzhiyski, Y., Sredovska, A., Ivanov, I. (2005) Evidence for non-enzymatic glycosylation of Escherichia coli chromosomal DNA. Mol. Microbiol. 55, 1801-1811.
14. Gomes, R. A., Miranda, H. V., Silva, M. S., Graca, G., Coelho, A. V., Ferreira, A. E., Cordeiro, C., Freire, A. P. (2006) Yeast protein glycation in vivo by methylglyoxal. Molecular modification of glycolytic enzymes and heat shock proteins. FEBS J. 273, 5273-5287.
15. Poggioli, S., Bakala, H., Friguet, B. (2002) Age-related increase of protein glycation in peripheral blood lymphocytes is restricted to preferential target proteins. Exp. Gerontol. 37, 1207-1215.
16. Poggioli, S., Mary, J., Bakala, H., Friguet, B. (2004) Evidence of preferential protein targets for age-related modifications in peripheral blood lymphocytes. Ann. N. Y. Acad. Sci. 1019, 211-214.
17. Price, C. L., Sharp, P. S., North, M. E., Rainblow, S. J., Knight, S. C. (2004) Advanced glycation end products modulate the maturation and function of peripheral blood dendritic cells. Diabetes 53, 1452-1458.
18. Donato, R. (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668.
19. Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., Neurath, M. F., Slattery, T., Beach, D., McClary, J., Nagashima, M., Morser, J., Stern, D., Schmidt, A. M. (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889-901.
20. Huttunen, H. J., Kuja-Panula, J., Sorci, G., Agneletti, A. L., Donato, R., Rauvala, H. (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 275, 40096-40105.
21. Tang, D., Shi, Y., Kang, R., Li, T., Xiao, W., Wang, H., Xiao, X. (2007) Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1. J. Leukoc. Biol. 81, 741-747.
22. Dumitriu, I. E., Bianchi, M. E., Bacci, M., Manfredi, A. A., Rovere-Querini, P. (2007) The secretion of HMGB1 is required for the migration of maturing dendritic cells. J. Leukoc. Biol. 81, 84-91.
23. Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J., Nagashima, M., Nitecki, D., Morser, J., Stern, D., Schmidt, A. M. (1995) The receptor for advanced glycation endproducts (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752-25761.
24. Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., Hofmann, M. A., Kislinger, T., Ingram, M., Lu, A., Tanaka, H., Hori, O., Ogawa, S., Stern, D. M., Schmidt, A. M. (2000) Blockade of amphoterin/RAGE signaling suppresses tumor growth and metastases. Nature 405, 354-360.
25. Wang, H., Bloom, O., Zhang, M., Vishnuhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., Manogue, K. R., Faist, E., Abraham, E., Andersson, J., Andersson, U., Molina, P. E., Abumrad, N. N., Sama, A., Tracey, K. J. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251.
26. Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., Yang, H. (2006) HMGB1 signals through Toll-like receptor (TLR) 4 and TLR2. Shock 26, 174-179.
27. Dumitriu, I. E., Baruah, P., Valentinis, B., Voll, R. E., Hermann, M., Nawroth, P. P., Arnold, B., Bianchi, M. E., Manfredi, A. A., Rovere-Querini, P. (2005) Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation endproducts. J. Immunol. 174, 7506-7515.
28. Chavakis, T., Bierhaus, A., Al-Fakhri, N., Schneider, D., Witte, S., Linn, T., Nagashima, M., Morser, J., Arnold, B., Preissner, K. T., Nawroth, P. P. (2003) The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 198, 1507-1515.
29. Orlova, V. V., Choi, E. Y., Xie, C., Chavakis, E., Bierhaus, A., Ihanus, E., Ballantyne, C. M., Gahmberg, C. G., Bianchi, M. E., Nawroth, P. P., Chavakis, T. (2007) A novel pathway of HMGB1-medaited inflammatory cell recruitment that requires Mac-1 integrin. EMBO J. 26, 1129-1139.
30. Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Godman, G., Stern, D., Schmidt, A. M. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
31. Yan, S. D., Zhu, H., Zhu, A., Golabek, A., Du, H., Roher, A., Yu, J., Soto, C., Schmidt, A. M., Stern, D., Kindy, M. (2000) Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat. Med. 6, 643-651.
32. Ma, W., Lee, S. E., Guo, J., Qu, W., Hudson, B. I., Schmidt, A. M., Barile, G. R. (2007) RAGE ligand upregulation of VEGF secretion in ARPE-19 cells. Invest. Ophthalmol. Vis. Sci. 48, 1355-1361.
33. Woltjer, R. L., Maezawa, I., Ou, J. J., Montine, K. S., Montine, T. J. (2003) Advanced glycation endproduct precursor alters intracellular amyloid-β/A β PP carboxy-terminal fragment aggregation and cytotoxicity. J. Alzheimers Dis. 5, 467-476.
34. Obrenovich, M. E., Monnier, V. M. (2004) Glycation stimulates amyloid formation. Sci. Aging Knowledge Environ. 2004, pe3.
35. Miyata, T., Taneda, S., Kawai, R., Ueda, Y., Horiuchi, S., Hara, M., Maeda, K., Monnier, V. M. (1996) Identification of pentosidine as a native structure for advanced glycation endproducts in β-2 microglobulin containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc. Natl. Acad. Sci. USA 93, 2353-2358.
36. Xie, J., Burz, D. S., He, W., Bronstein, I. B., Lednev, I., Shekhtman, A. (2007) Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J. Biol. Chem. 282, 4218-4231.
37. Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., Schmidt, A. M. (1997) Activation of the receptor for advanced glycation endproducts triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J. Biol. Chem. 272, 17810-17814.
38. Schmidt, A. M., Hori, O., Chen, J. X., Li, J. F., Crandall, J., Zhang, J., Cao, R., Yan, S. D., Brett, J., Stern, D. (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96, 1395-1403.
39. Marsche, G., Semlitsch, M., Hammer, A., Frank, S., Weigle, B., Demling, N., Schmidt, K., Windischhofer, W., Waeg, G., Sattler, W., Malle, E. (2007) Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-ERK 1/2 MAP-kinase pathway. FASEB J. 21, 1145-1152.
40. Zeng, S., Feirt, N., Goldstein, M., Guarrera, J., Ippagunta, N., Ekong, U., Dun, H., Lu, Y., Qu, W., Schmidt, A. M., Emond, J. C. (2004) Blockade of receptor for advanced glycation endproducts (RAGE) attenuates ischemia and reperfusion injury in the liver in mice. Hepatology 39, 422-432.
41. Reddy, M. A., Li, S. L., Sahar, S., Kim, Y. S., Xu, Z. G., Lanting, L., Natarajan, R. (2006) Key role of Src kinase in S100b-induced activation of the receptor for advanced glycation endproducts in vascular smooth muscle cells. J. Biol. Chem. 281, 13685-13693.
42. Sakaguchi T., Yan, S. F., Yan, S. D., Rong, L. L., Sousa, M., Belov, D., Andrassy, M., Marso, S. P., Duda, S., Arnold, B., Liliensiek, B., Nawroth, P. P., Stern, D. M., Schmidt, A. M., Naka, Y. (2003) Arterial restenosis: central role of RAGE-dependent neointimal expansion. J. Clin. Invest. 111, 959-972.
43. Bianchi, R., Adami, C., Giamanco, I., Donato, R. (2007) S100b binding to RAGE in microglia stimulates COX-2 expression. J. Leukoc. Biol. 81, 108-118.
44. Fukami, K., Ueda, S., Yamaghishi, S., Kato, S., Inagaki, Y., Takeuchi, M., Motomiya, Y., Bucala, R., Iida, S., Tamaki, K., Imaizumi, T., Cooper, M. E., Okuda, S.. (2004) AGEs activate mesangial TGF-β-Smad signaling via an angiotensin II type 1 receptor interaction. Kidney Int. 66, 2137-2147.
45. Vincent, A. M., Perrone, L., Sullivan, K. A., Backus, C., Sastry, A. M., Lastoskie, C., Feldman, E. L. (2007) Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148, 548-558.
46. Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M., Kasaoka, T. (2003) The receptor for advanced glycation endproducts (RAGE) directly binds to ERK by a D-domain like docking site. FEBS Lett. 550, 107-113.
47. Sorci, G., Riuzzi, F., Agneletti, A. L., Marchetti, C., Donato, R. (2003) S100b inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol. Cell. Biol. 23, 4870-4881.
48. Horiuchi, S., Unno, Y., Usui, H., Shikata, K., Takaki, K., Koito, W., Sakamoto, Y., Nagai, R., Makino, K., Sasao, A., Wada, J., Makino, H. (2005) Pathological roles of advanced glycation end product receptors SR-1 and CD36. Ann. N. Y. Acad. Sci. 1043, 671-675.
49. Hofmann, M. A., Drury, S., Hudson, B. I., Gleason, M. R., Qu, W., Lu, Y., Lalla, E., Chitnis, S., Monteiro, J., Stickland, M. H., Bucciarelli, L. G., Moser, B., Moxley, G., Itescu, S., Grant, P. J., Gregersen, P. K., Stern, D. M., Schmidt, A. M. (2002) RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 3, 123-135.
50. Liliensiek, B., Weigand, M. A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., Plachky, J., Grone, H. J., Kurschus, F. C., Schmidt, A. M., Yan, S. D., Martin, E., Schleicher, E., Stern, D. M., Hammerling, G. G., Nawroth, P. P., Arnold, B. (2004) Receptor for advanced glycation end-products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 113, 1641-1650.
51. Chen, Y., Yan, S. S., Colgan, J., Zhang, H. P., Luban, J., Schmidt, A. M., Stern, D., Herold, K. C. (2004) Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products. J. Immunol. 173, 1399-1405.
52. Moser, B., Szabolcs, M. J., Ankersmit, H. J., Lu, Y., Qu, W., Weinberg, A., Herold, K. C., Schmidt, A. M. (2007) Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in heart transplantation. Am. J. Transplant. 7, 293-302.
53. Yan, S. S. D., Wu, Z. Y., Zhang, H. P., Furtado, G., Chen, X., Yan, S. F., Schmidt, A. M., Brown, C., Stern, A., LaFaille, J., Chess, L., Stern, D. M., Jiang, H. (2003) Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system. Nat. Med. 9, 287-293.
54. Moser, B., Desai, D. D., Chen, Y., Downie, M. P., Roth, G., Hudson, B. I., Szabolcs, M. J., Ankersmit, J. H., Herold, K., Schmidt, A. M., Clynes, R. (2005) RAGE (receptor for advanced glycation endproducts) is required for effective T cell priming in vivo. Circulation Suppl. II 112, 1596.
55. Cataldegirmen, G., Zeng, S., Feirt, N., Ippagunta, N., Dun, H., Qu, W., Lu, Y., Rong, L. L., Hofmann, M. A., Kislinger, T., Pachydaki, S. I., Jenkins, D. G., Weinberg, A., Lefkowitch, J., Rogiers, X., Yan, S. F., Schmidt, A. M., Emond, J. (2005) RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-α and NF-κB. J. Exp. Med. 201, 473-484.
56. Rong, L. L., Trojaborg, W., Qu, W., Kostov, K., Yan, S. D., Gooch, C., Szabolcs, M., Hays, A. P., Schmidt, A. M. (2004) Antagonism of RAGE suppresses peripheral nerve regeneration. FASEB J. 18, 1812-1817.
57. Rong, L. L., Yan, S. F., Wendt, T., Hans-Wagner, D., Pachydaki, S., Bucciarelli, L. G., Adebayo, A., Qu, W., Lu, Y., Kostov, K., Lalla, E., Yan, S. D., Gooch, C., Szabolcs, M., Trojaborg, W., Hays, A. P., Schmidt, A. M. (2004) RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways. FASEB J. 18, 1818-1825.
58. Goova, M. T., Li, J., Kislinger, T., Qu, W., Lu, Y., Bucciarelli, L. G., Nowygrod, S., Wolf, B. M., Caliste, X., Yan, S. F., Stern, D. M., Schmidt, A. M. (2001) Blockade of receptor for AGE (RAGE) restores effective wound healing in diabetic mice. Am. J. Pathol. 159, 513-525.
59. Lalla, E., Lamster, I. B., Feit, M., Huang, L., Spessot, A., Qu, W., Kislinger, T., Lu, Y., Stern, D. M., Schmidt, A. M. (2000) Blockade of RAGE suppresses periodontitis-associated alveolar bone loss in diabetic mice. J. Clin. Invest. 105, 1117-1124.